Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer-Reference-Cited by-同舟云学术

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

Published:2014-09-25 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Pritchard Colin C.,Morrissey Colm,Kumar Akash,Zhang Xiaotun,Smith Christina,Coleman Ilsa,Salipante Stephen J.,Milbank Jennifer,Yu Ming,Grady William M.,Tait Jonathan F.,Corey Eva,Vessella Robert L.,Walsh Tom,Shendure Jay,Nelson Peter S.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms5988.pdf

Reference22 articles.

1. Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl Acad. Sci. USA 108, 17087–17092 (2011).

2. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685–689 (2012).

3. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).

4. Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67–73 (2013).

5. Pritchard, C. C. et al. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J. Mol. Diagn. 14, 357–366 (2012).

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

2. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway;International Journal of Molecular Sciences;2024-06-26

3. Germline and somatic mutations in prostate cancer: Implications for treatment;Current Problems in Cancer;2024-06

4. New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-06

5. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study;Hepatology Communications;2024-03-29